Bausch + Lomb Corporation (BLCO)
NYSE: BLCO
· Real-Time Price · USD
11.29
0.04 (0.36%)
At close: May 23, 2025, 3:59 PM
11.28
-0.01%
After-hours: May 23, 2025, 05:16 PM EDT
Bausch + Lomb Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|
| Branded and Other Generic Products Revenue | 281M | 252M |
| Branded and Other Generic Products Revenue Growth | +11.51% | n/a |
| Device Products Revenue | 1.8B | 1.65B |
| Device Products Revenue Growth | +9.09% | n/a |
| Other Revenues Revenue | 17M | 15M |
| Other Revenues Revenue Growth | +13.33% | n/a |
| Over the Counter Products Revenue | 1.72B | 1.61B |
| Over the Counter Products Revenue Growth | +7.01% | n/a |
| Pharmaceutical Products Revenue | 969M | 618M |
| Pharmaceutical Products Revenue Growth | +56.80% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| Canada Revenue | 127M | 110M | 101M |
| Canada Revenue Growth | +15.45% | +8.91% | n/a |
| China Revenue | 358M | 344M | 343M |
| China Revenue Growth | +4.07% | +0.29% | n/a |
| France Revenue | 227M | 210M | 195M |
| France Revenue Growth | +8.10% | +7.69% | n/a |
| Germany Revenue | 152M | 147M | 138M |
| Germany Revenue Growth | +3.40% | +6.52% | n/a |
| Italy Revenue | 91M | 82M | 72M |
| Italy Revenue Growth | +10.98% | +13.89% | n/a |
| Japan Revenue | 180M | 187M | 192M |
| Japan Revenue Growth | -3.74% | -2.60% | n/a |
| Mexico Revenue | 75M | 68M | 55M |
| Mexico Revenue Growth | +10.29% | +23.64% | n/a |
| Other Countries Revenue | 759M | 655M | 572M |
| Other Countries Revenue Growth | +15.88% | +14.51% | n/a |
| Poland Revenue | 65M | 51M | 44M |
| Poland Revenue Growth | +27.45% | +15.91% | n/a |
| Spain Revenue | 92M | 85M | 77M |
| Spain Revenue Growth | +8.24% | +10.39% | n/a |
| United States And Puerto Rico Revenue | 2.41B | 1.93B | 1.7B |
| United States And Puerto Rico Revenue Growth | +24.77% | +14.10% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 563M | 532M | 511M | 535M | 504M | 483M | 418M | 417M | 418M | 386M | 381M | 368M | 343M | 365M | 348M | 358M | 318M | 331M | 312M | 305M | 305M |
| Selling, General, and Administrative Revenue Growth | +5.83% | +4.11% | -4.49% | +6.15% | +4.35% | +15.55% | +0.24% | -0.24% | +8.29% | +1.31% | +3.53% | +7.29% | -6.03% | +4.89% | -2.79% | +12.58% | -3.93% | +6.09% | +2.30% | 0.00% | n/a |
| Research and Development Revenue | 86M | 93M | 84M | 84M | 82M | 80M | 82M | 85M | 77M | 78M | 77M | 75M | 77M | 70M | 63M | 71M | 67M | 66M | 61M | 63M | 63M |
| Research and Development Revenue Growth | -7.53% | +10.71% | 0.00% | +2.44% | +2.50% | -2.44% | -3.53% | +10.39% | -1.28% | +1.30% | +2.67% | -2.60% | +10.00% | +11.11% | -11.27% | +5.97% | +1.52% | +8.20% | -3.17% | 0.00% | n/a |